Monitoring of EAE onset and progression in the common marmoset monkey by sequential high-resolution 3D MRI

Susann Boretius1, Barthel Schmelting, Takashi Watanabe

  • 1Biomedizinische NMR Forschungs GmbH am Max-Planck-Institut für Biophysikalische Chemie, 37070 Göttingen, Germany. sboreti@gwdg.de

NMR in Biomedicine
|January 13, 2006
PubMed

Insights

Experimental autoimmune encephalomyelitis (EAE) in marmosets, induced by myelin-oligodendrocyte glycoprotein (MOG), serves as a multiple sclerosis model. MRI and disability scoring effectively track disease progression, aiding therapeutic evaluation.

Area of Science:

  • Neuroscience
  • Immunology
  • Primate Models

Background:

  • Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS).
  • Experimental autoimmune encephalomyelitis (EAE) is a widely used animal model to study MS pathogenesis.
  • Myelin-oligodendrocyte glycoprotein (MOG) is a key autoantigen in EAE induction.

Purpose of the Study:

  • To establish and characterize a novel model of EAE in common marmosets (Callithrix jacchus) induced by MOG.
  • To assess the utility of magnetic resonance imaging (MRI) and detailed clinical scoring for monitoring disease progression in this model.
  • To evaluate the potential of this marmoset EAE model for preclinical testing of therapeutic interventions.

Main Methods:

  • Induction of EAE in common marmosets using recombinant rat MOG.
  • High-resolution 3D T1- and T2-weighted MRI for cerebral lesion detection and characterization.
  • Detailed neurological disability scoring system tailored to CNS symptoms.
  • Histopathological confirmation of MRI findings.

Main Results:

  • Successful induction of EAE in all marmosets, characterized by cerebral lesions and neurological deficits.
  • Significant interindividual heterogeneity in disease onset, lesion localization, duration, and severity was observed.
  • MRI detected cerebral white matter lesions correlating well with the onset of CNS symptoms.
  • No spontaneous recovery was observed during the study period.

Conclusions:

  • Marmoset EAE induced by MOG is a relevant preclinical model for multiple sclerosis.
  • Combined MRI monitoring and refined disability scoring provide a robust method for tracking disease.
  • This model's heterogeneity and sensitivity to early changes make it suitable for evaluating novel therapeutic strategies.

Related Concept Videos